FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240207E00330
1. Date of relevant event: 17/01/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later): 02/02/2024
(dd/mm/yyyy)
3. Stock code: 02216
4. Name of listed corporation: Broncus Holding Corporation - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 527,198,076
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) ZI
(Other names) Zhenjun
10. Name of director (Chinese): 訾振軍 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2201Interest of corporation controlled by you
 
 
6,816,641         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position99,138,59318.80
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position92,321,95217.51
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position90,017,823
2101Beneficial owner
Long position2,304,129
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
  USD0USD0.258USD0.0002,160,000
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Xin Nuo Tong Investment LimitedWickhams Cay II, Road Town, Tortola, VG1110, Virgin Islands (British) (British Virgin Islands)Zhenjun ZI100.00Y
Long position9,172,328
Xin Nuo Tong Investment LimitedWickhams Cay II, Road Town, Tortola, VG1110, Virgin Islands (British) (British Virgin Islands)Zhenjun ZI100.00N
Long position33,089,155
Dinova Capital LimitedP.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Xin Nuo Tong Investment Limited100.00N
Long position25,245,257
Dinova Venture Partners GP III, L.P.P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Dinova Capital Limited (as general partner); Zhenjun ZI (as limited partner holding approximately 33.33% interest)100.00Y
Long position3,460,008
Dinova Venture Partners GP III, L.P.P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Dinova Capital Limited (as general partner); Zhenjun ZI (as limited partner holding approximately 33.33% interest)100.00N
Long position21,785,249
Dinova Healthcare Gamma Fund (USD), L.P.P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Dinova Venture Partners GP III, L.P.100.00N
Long position21,785,249
Broncus Biomedical LimitedRoom 1508, Beverly House, 93-107 Lockhart Road, Wanchai, Hong Kong (Hong Kong)Dinova Healthcare Gamma Fund (USD) L.P.100.00Y
Long position21,785,249
Dinova Venture Partners LimitedP.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Zhenjun ZI33.33N
Long position14,643,588
Dinova Venture Partners GP II, L.P.P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Dinova Venture Partners Limited100.00N
Long position14,643,588
Dinova Venture Partners LP II, L.P.P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman, Cayman Islands KY1-1106 (Cayman Islands)Dinova Venture Partners GP II, L.P.100.00N
Long position14,643,588
BRS Biomedical LimitedKingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands (British Virgin Islands)Dinova Venture Partners LP II, L.P.100.00Y
Long position14,643,588
Hangzhou Denuo Commercial Information Consulting Co., Ltd. (杭州德諾商務資訊諮詢有限公司)中國杭州市濱江區西興街道江陵路88號2幢3樓302室 (中國)Zhenjun ZI40.00N
Long position33,112,752
Zhejiang Denuo Capital Management L.P. (浙江德諾資本管理合夥企業(有限合夥))中國杭州市濱江區西興街道江陵路88號2幢3樓303室 (中國)Hangzhou Denuo Commercial Information Consulting Co., Ltd. (as general partner); Zhenjun ZI (as limited partner holding 39.60% interest)100.00N
Long position33,112,752
Zhejiang Dinova Ruiying Venture Investment L.P. (浙江德諾瑞盈創業投資合夥企業(有限合夥))中國杭州市濱江區西興街道江陵路88號2幢3樓304室 (中國)Zhejiang Denuo Capital Management L.P. (浙江德諾資本管理合夥企業(有限合夥))100.00N
Long position33,112,752
Dinova Healthcare (Hong Kong) Co., LimitedRoom 1508, Beverly House, 93-107 Lockhart Road, Wanchai, Hong Kong (Hong Kong)Zhejiang Dinova Ruiying Venture Investment L.P. (浙江德諾瑞盈創業投資合夥企業(有限合夥))100.00Y
Long position33,112,752
Dinova Venture Capital LimitedPO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Xin Nuo Tong Investment Limited40.00N
Long position7,843,898
Dinova Venture Partners GP IV L.P.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Dinova Venture Capital Limited100.00Y
Long position1,799,015
Dinova Venture Partners GP IV L.P.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Dinova Venture Capital Limited100.00N
Long position6,044,883
Dinova Healthcare Delta Fund (USD) L.P.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Dinova Venture Partners GP IV L.P.100.00Y
Long position6,044,883
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: The decrease is due to the transfer of shares from Dinova Healthcare Delta Fund (USD) L.P. to Dinova Venture Partners GP IV L.P. and other four individuals/entities through a distribution in kind as requested by limited partners of Dinova Healthcare Delta Fund (USD) L.P.. For Box 28: Mr. Zhenjun Zi has vested 2,160,000 RSU, which were granted to him pursuant to the RSU Scheme and have not been transferred to him as Broncus (2216.HK) has not received the payment of consideration from Mr. Zi.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 07/02/2024
(dd/mm/yyyy)